Real-World Study on Chinese Medicine for Treating Chikungunya Fever

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-26

Study Completion Date

2026-12-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effectiveness and safety of Chinese Medicine-used alone or combined with Western medicine-in treating chikungunya fever, a mosquito-borne viral disease causing fever, rash, and severe joint pain. With recent outbreaks in China (including over 3,000 cases in Foshan, Guangdong) and no specific antiviral treatment available, Chinese medicine may offer a valuable therapeutic option based on its symptom-relief and syndrome-specific approach.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms

NCT01973855

Viral Haemorrhagic Fever Dengue Fever

UNKNOWN PHASE2

Effect of Traditional Chinese Medicine of Severe COVID-19

NCT06714032

Severe COVID-19

COMPLETED PHASE3

Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome

NCT06703788

Obesity Metabolic Syndrome Dyslipidemias +1 more

RECRUITING PHASE1/PHASE2

An Examination of Blinding for Chinese Herbal Oral Liquid and Matched Placebo

NCT05483595

Placebo Evaluate

COMPLETED NA

Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia

NCT05692258

Acupuncture Covid-19 Omicron Pulmonary Function

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chikungunya Fever

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chinese Medicine Group

Intervention: Patients receive only TCM treatments, which may include herbal formulas (e.g., decoctions, granules) or acupuncture, tailored to their syndrome differentiation (e.g., heat-clearing, detoxifying, or dampness-resolving therapies).

No interventions assigned to this group

Western Medicine Group

Intervention: Patients receive only standard Western medical care, which may include antipyretics (e.g., acetaminophen), NSAIDs for pain, and supportive treatments (e.g., hydration).

No interventions assigned to this group

Integrated Therapy Group

Intervention: Patients receive both Chinese and Western treatments.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Meets the suspected or confirmed diagnostic criteria for chikungunya fever;
2. Symptom onset ≤3 days before enrollment;
3. Actual prescribed treatment aligns with the study's group assignment (TCM, Western medicine, or combined therapy)
4. Signed informed consent form

Exclusion Criteria

1. Severe chikungunya fever;
2. Participation in another drug clinical trial within the past 3 months;
3. Any other condition deemed by the investigator as unsuitable for enrollment.

Eligible Sex

ALL

Accepts Healthy Volunteers

No